Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Korman, Yang Zhao, Yunfeng Li, M. Liao, M. Tran (2015)
Clinical symptoms and self-reported disease severity among patients with psoriasis – Implications for psoriasis managementJournal of Dermatological Treatment, 26
P. Austin (2011)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational StudiesMultivariate Behavioral Research, 46
W. Carey, S. Glazer, A. Gottlieb, M. Lebwohl, C. Leonardi, A. Menter, K. Papp, A. Rundle, D. Toth (2006)
Relapse, rebound, and psoriasis adverse events: an advisory group report.Journal of the American Academy of Dermatology, 54 4 Suppl 1
J. Sturm, G. Donnan, H. Dewey, R. Macdonell, A. Gilligan, V. Srikanth, A. Thrift (2004)
Quality of Life After Stroke: The North East Melbourne Stroke Incidence Study (NEMESIS)Stroke, 35
M. Reilly, A. Zbrozek, E. Dukes (1993)
The Validity and Reproducibility of a Work Productivity and Activity Impairment InstrumentPharmacoEconomics, 4
M. Augustin, M. Radtke (2014)
Quality of life in psoriasis patientsExpert Review of Pharmacoeconomics & Outcomes Research, 14
S. Kurd, A. Troxel, P. Crits-Christoph, J. Gelfand (2010)
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.Archives of dermatology, 146 8
Jacob Jones, C. Hass, Paul Mangal, Jacob Lafo, M. Okun, D. Bowers (2014)
The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?Parkinsonism & related disorders, 20 11
A. Armstrong, C. Schupp, Julie Wu, B. Bebo (2012)
Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011PLoS ONE, 7
S. Normand, M. Landrum, E. Guadagnoli, J. Ayanian, J. Ayanian, T. Ryan, P. Cleary, B. Mcneil, B. Mcneil (2001)
Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores.Journal of clinical epidemiology, 54 4
A. Williams (1990)
EuroQol : a new facility for the measurement of health-related quality of lifeHealth Policy, 16
A. Reich, E. Hrehorów, J. Szepietowski (2010)
Pruritus is an important factor negatively influencing the well-being of psoriatic patients.Acta dermato-venereologica, 90 3
L. Keele (2010)
An overview of rbounds: An R package for Rosenbaum bounds sensitivity analysis with matched data.
V. Orgeta, R. Edwards, B. Hounsome, M. Orrell, B. Woods (2014)
The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carersQuality of Life Research, 24
Peter Anderson, M. Benford, N. Harris, M. Karavali, James Piercy (2008)
Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understandCurrent Medical Research and Opinion, 24
R. Langley, G. Krueger, C. Griffiths (2005)
Psoriasis: epidemiology, clinical features, and quality of lifeAnnals of the Rheumatic Diseases, 64
S. Walters, J. Brazier (2005)
Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6DQuality of Life Research, 14
A. Kimball, C. Jacobson, S. Weiss, M. Vreeland, Ying Wu (2005)
The Psychosocial Burden of PsoriasisAmerican Journal of Clinical Dermatology, 6
Alberto Abadie, G. Imbens (2009)
Matching on the Estimated Propensity ScoreNBER Working Paper Series
A. Finlay, G. Khan (1994)
Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical useClinical and Experimental Dermatology, 19
BackgroundPsoriasis impairs health-related quality of life (HRQoL).ObjectiveTo improve understanding of flare burden in patients with moderate to severe psoriasis.MethodsA retrospective, cross-sectional study comparing data in U.S. patients with and without psoriasis flares. Physicians identified flaring patients as those not in remission, or in remission < 12 weeks, with worsening/unstable disease progression.ResultsOverall health status (EQ-5D-3L) was reduced in flaring versus matched non-flaring patients (P = .001); this difference was clinically meaningful (> 0.074 difference in absolute value). Reduced HRQoL and activity impairment, measured by Dermatology Life Quality Index (P = .0178) and Work Productivity and Activity Impairment Questionnaire (P = .0002), respectively, were observed in flaring versus non-flaring patients. Anxiety was associated with flaring (P = .0139). Flaring patients were less satisfied with treatment effectiveness than non-flaring patients (P < .0001). The flaring group experienced a median of two flares over 12 months.ConclusionFlares are associated with reduced health status and HRQoL and lower treatment satisfaction.
Journal of Psoriasis and Psoriatic Arthritis – SAGE
Published: Jun 1, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.